Leary’s impact on, 9 , 185 –86, 190 , 198 –99, 212 , 219 –20
and LSD therapy for alcoholism, 148 –52
and methodological issues, 152 , 208
and moral panic provoked by psychedelics, 185 , 205
and psychedelics’ escape from the lab, 157 –58, 197
and psycholytic model, 154 –57
and psychotomimetic model, 145 –50
researchers’ consumption of drugs, 146 , 148 , 189 , 195 , 208
reunion of figures in (1979), 218 –20
at Saskatchewan Mental Hospital in Canada, 147 –50
skepticism toward, 144
at Spring Grove facilities, 52 , 56 –58, 59 , 218
structured approaches/protocols of, 214 –15
suppression of, 44 , 57 –58, 60 , 141 –42, 332
and terminal patients, 338 –40
volume and scope of, 44 –45, 141 –42
See also Central Intelligence Agency (CIA); Harvard Psilocybin Project
research on psychedelics, second wave
absence of adverse events in, 14 –15
and betterment of well people, 45 , 51 , 78 , 401 , 404
challenges faced by, 333 –34
and counterculture of the sixties, 84
critics of, 76
and CSP website, 43
and discoveries of first-wave research, 332
and exuberance of researchers, 26 –27, 381 , 382
FDA protocols on, 48
federal sanctioning of, 48
and Hofmann’s 100th birthday celebration/symposium, 21 –22, 26 –27
Jesse’s role in, 34 –35
and methodological issues, 333 –34
and phase 3 trials for psychedelics, 397 , 400
replication of Good Friday experiment, 192
role of scientific outsiders in, 34 –35
with synthetic psilocybin, 83 –84
and underground therapists, 227
See also cancer patient research
Rheingold, Howard, 183
Richards, Bill
on authenticity questions, 347
as bridge between first/second eras, 52 –53
flight instructions prepared by, 63 , 72
and Jesse, 52 , 53
and Pahnke, 53 , 54 –55
and psilocybin trials at Hopkins, 60 –61
psychedelic experiences of, 53 –55
at Spring Grove, 52 , 56 –58, 218
and terminal patients, 339
risky behaviors of people on psychedelics, 14
rite of passage, psychedelic trips as, 3 , 216 , 246
frankie
(Frankie)
#1